Our research teams have made significant basic science contributions to the study of infectious disease-causing organisms and are paving the way for new therapies.
A trainee in the doctoral program in biochemistry has been awarded a two-year predoctoral fellowship from the American Heart Association for her research on a fatal neurodegenerative disorder.
As the COVID-19 pandemic maintains its grip on the world, physicians at the Jacobs School of Medicine and Biomedical Sciences continue to step up in a myriad of ways to help the Western New York community.
A team of researchers in the Jacobs School of Medicine and Biomedical Sciences have developed a new, high-throughput screening method designed to quickly screen antiviral candidates against the SARS-CoV2 virus.
T Regulatory cell responses in Toxoplasma-infected muscle. Elizabeth Wohlfert (Principal Investigator). NIAID/NIH. $2,445,371. 2/1/2022-3/1/2027.
MARCH proteins, members of a host protein family that targets HIV. Spyridon Stavrou (Principal Investigator). NIH/NIAID. $1,974,920. 12/1/2021-11/1/2026.
Ribosome Heterogeneity in C. neoformans. John Panepinto (Principal Investigator). NIAID / NIH. 8/1/2021-7/1/2026.